Skip to main content
IL DONG PHARMACEUTICAL CO., LTD. logo

IL DONG PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 249420 ISIN · KR7249420001 KO Manufacturing
Open in API
Filings indexed 392 across all filing types
Latest filing 2026-02-10 Report Publication Anno…
Country KR South Korea
Listing KO 249420

About IL DONG PHARMACEUTICAL CO., LTD.

https://mobile.ildong.com/eng/main/main…

IL DONG PHARMACEUTICAL CO., LTD. is a pharmaceutical company engaged in the research, development, manufacturing, and commercialization of a broad range of healthcare products. The company's portfolio encompasses ethical drugs, over-the-counter (OTC) medications, active pharmaceutical ingredients (APIs), and health functional foods. Key therapeutic areas of focus include metabolic disorders, gastrointestinal diseases, degenerative diseases, oncology, and cardiovascular conditions. Its robust research and development pipeline features promising drug candidates such as an oral GLP-1 receptor agonist for diabetes and obesity, a P-CAB class treatment for peptic ulcers, and a first-in-class CXCR7 agonist for fibrotic diseases. Utilizing its GMP-certified facilities, the company also offers contract manufacturing (CMO) services, with specialized capabilities in antibiotics and oncology drugs, while actively pursuing global expansion through strategic partnerships and licensing.

Recent filings

Filing Released Lang Actions
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement from Ildong Pharmaceutical regarding the upcoming release date of their annual financial results (2025-01-01 to 2025-12-31). It explicitly states that the actual financial data will be published on a future date (2026-02-11). Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2026-02-10 Korean
[기재정정]타법인주식및출자증권처분결정
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from Il Dong Pharmaceutical regarding the 'Decision to Dispose of Shares and Securities of Other Corporations'. It is a correction report (정정신고) detailing the finalization of a share disposal process, including changes in the number of shares sold and the finalization of the disposal period. This type of corporate disclosure regarding the sale of assets or equity investments falls under general regulatory filings as it does not fit into specific categories like M&A (which usually implies control changes) or share buybacks (which would be POS). Therefore, it is classified as a Regulatory Filing (RNS).
2026-02-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 95% confidence The document is a regulatory filing from Ildong Pharmaceutical regarding a significant change in sales or profit structure (30% or more). It provides preliminary financial results (revenue, operating profit, net income) for the fiscal year 2025 compared to 2024. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for reporting preliminary earnings before the final audit report is published. Since it is an initial announcement of financial results rather than a full annual report or a simple report publication notice, it falls under the Earnings Release (ER) category. FY 2025
2026-01-27 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the change of the company's CEO (Representative Director) at Ildong Pharmaceutical. It details the names of the outgoing and incoming directors, the reason for the change, the effective date, and the professional background of the new appointee. This falls directly under the category of board or management changes.
2026-01-05 Korean
타법인주식및출자증권처분결정
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the decision to dispose of shares and investment securities of another company. It includes details such as the number of shares to be disposed, disposal amount, ownership percentages before and after disposal, purpose of disposal, scheduled disposal date, board resolution date, attendance of outside directors and auditors, and related financial summary of the issuing company. The document is not a financial report, audit report, or earnings release but rather a specific corporate action announcement related to share disposal. This fits the category of Regulatory Filings (RNS) as it is a general regulatory announcement about a corporate transaction that does not fit into more specific categories like Capital/Financing Update or Transaction in Own Shares (since it concerns disposal of shares in another company, not own shares). The document length is short (2252 characters), and it is a standalone announcement without detailed financial statements or analysis.
2025-11-07 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 95% confidence The document is a Korean-language announcement of preliminary (잠정) consolidated financial results for the third quarter of 2025, including sales, operating profit, net income, and comparisons to prior periods. It explicitly states that the figures are provisional and unaudited, prepared under K-IFRS, and subject to change upon external audit completion. The document is short (2284 characters) and formatted as a public disclosure (공정공시) to investors and media. It does not contain full financial statements or detailed analysis but rather summarized key financial metrics for a quarterly period. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights only. It is not a full Interim/Quarterly Report (IR) because it lacks comprehensive financial statements and substantive analysis. It is not a Report Publication Announcement (RPA) because it contains actual financial data, not just a notice of report availability. 9M 2025
2025-11-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.